Michael D. Roth

12.9k total citations
125 papers, 6.9k citations indexed

About

Michael D. Roth is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Michael D. Roth has authored 125 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 47 papers in Pathology and Forensic Medicine and 41 papers in Immunology. Recurrent topics in Michael D. Roth's work include Systemic Sclerosis and Related Diseases (42 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers) and Immunotherapy and Immune Responses (22 papers). Michael D. Roth is often cited by papers focused on Systemic Sclerosis and Related Diseases (42 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (39 papers) and Immunotherapy and Immune Responses (22 papers). Michael D. Roth collaborates with scholars based in United States, Japan and United Kingdom. Michael D. Roth's co-authors include Donald P. Tashkin, Sylvia M. Kiertscher, Steven M. Dubinett, Gayle Cocita Baldwin, Jonathan Goldin, Philip J. Clements, Dinesh Khanna, Robert M. Elashoff, Daniel E. Furst and Theodore A. Sarafian and has published in prestigious journals such as The Journal of Experimental Medicine, Environmental Science & Technology and Blood.

In The Last Decade

Michael D. Roth

120 papers receiving 6.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Roth United States 51 2.2k 2.1k 1.8k 1.5k 1.1k 125 6.9k
Max Schlaak Germany 41 1.5k 0.7× 1.7k 0.8× 379 0.2× 424 0.3× 769 0.7× 275 7.5k
Robert J. Moots United Kingdom 47 3.6k 1.6× 1.4k 0.6× 502 0.3× 216 0.1× 593 0.5× 176 8.2k
Akihiro Yachie Japan 50 4.0k 1.8× 595 0.3× 1.1k 0.6× 423 0.3× 1.0k 0.9× 356 10.7k
Hyoung Doo Shin South Korea 43 1.3k 0.6× 629 0.3× 486 0.3× 556 0.4× 1.1k 1.0× 307 7.3k
Torleiv O. Rognum Norway 45 720 0.3× 1.1k 0.5× 1.2k 0.7× 213 0.1× 653 0.6× 170 7.1k
Kingo Chida Japan 50 1.1k 0.5× 3.5k 1.6× 473 0.3× 220 0.1× 1.7k 1.5× 290 6.8k
Mariana Castells United States 59 3.6k 1.6× 704 0.3× 684 0.4× 5.2k 3.5× 248 0.2× 228 10.3k
Anders Lindén Sweden 39 3.8k 1.7× 1.6k 0.7× 631 0.3× 141 0.1× 760 0.7× 195 8.1k
Carl J. Hauser United States 52 3.7k 1.7× 1.2k 0.6× 472 0.3× 272 0.2× 2.1k 1.9× 228 11.9k
Takafumi Suda Japan 52 1.4k 0.6× 5.6k 2.6× 784 0.4× 175 0.1× 2.5k 2.2× 531 9.9k

Countries citing papers authored by Michael D. Roth

Since Specialization
Citations

This map shows the geographic impact of Michael D. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Roth more than expected).

Fields of papers citing papers by Michael D. Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Roth. The network helps show where Michael D. Roth may publish in the future.

Co-authorship network of co-authors of Michael D. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Roth. A scholar is included among the top collaborators of Michael D. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Roth. Michael D. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Volkmann, Elizabeth R., Holly Wilhalme, Shervin Assassi, et al.. (2023). Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy. ACR Open Rheumatology. 5(10). 547–555. 7 indexed citations
2.
Assassi, Shervin, Elizabeth R. Volkmann, W. Jim Zheng, et al.. (2022). Peripheral blood gene expression profiling shows predictive significance for response to mycophenolate in systemic sclerosis-related interstitial lung disease. Annals of the Rheumatic Diseases. 81(6). 854–860. 21 indexed citations
3.
Kafaja, Suzanne, Philip J. Clements, Holly Wilhalme, et al.. (2017). Reliability and Minimal Clinically Important Differences of FVC. Results from the Scleroderma Lung Studies (SLS-I and SLS-II). American Journal of Respiratory and Critical Care Medicine. 197(5). 644–652. 86 indexed citations
4.
Tashkin, Donald P., Michael D. Roth, Philip J. Clements, et al.. (2015). Efficacy and Safety of Mycophenolate (MMF) Vs Oral Cyclophosphamide (CYC) for Treatment of Scleroderma-Interstitial Lung Disease (Ssc-ILD): Results of Scleroderma Lung Study II. CHEST Journal. 148(4). 637A–637A. 4 indexed citations
5.
Mao, Jenny T., Michael D. Roth, Michael C. Fishbein, et al.. (2011). Lung Cancer Chemoprevention with Celecoxib in Former Smokers. Cancer Prevention Research. 4(7). 984–993. 65 indexed citations
6.
Chao, Chun C., Lisa P. Jacobson, Frank J. Jenkins, et al.. (2008). Recreational Drug Use and Risk of Kaposi's Sarcoma in HIV- and HHV-8-Coinfected Homosexual Men. AIDS Research and Human Retroviruses. 25(2). 149–156. 9 indexed citations
7.
Strange, Charlie, Marcy B. Bolster, & Michael D. Roth. (2008). Prognostic Significance of Bronchoalveolar Lavage Cellular Analysis in Scleroderma Lung Disease. American Journal of Respiratory and Critical Care Medicine. 177(11). 1293–1293.
8.
Chao, Chun, Lisa P. Jacobson, Donald P. Tashkin, et al.. (2008). Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma. Cancer Causes & Control. 20(5). 509–516. 6 indexed citations
9.
Strange, Charlie, Marcy B. Bolster, Michael D. Roth, et al.. (2007). Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 177(1). 91–98. 92 indexed citations
10.
Basak, Saroj K., Sylvia M. Kiertscher, Airi Harui, & Michael D. Roth. (2004). Modifying Adenoviral Vectors for Use as Gene-Based Cancer Vaccines. Viral Immunology. 17(2). 182–196. 28 indexed citations
11.
Mao, Jenny T., Michael D. Roth, Kenneth J. Serio, et al.. (2003). Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.. PubMed. 9(16 Pt 1). 5835–41. 38 indexed citations
12.
Roth, Michael D., et al.. (2003). Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. Journal of Neuroimmunology. 147(1-2). 82–86. 55 indexed citations
13.
Roth, Michael D., Qingwen Cheng, Airi Harui, et al.. (2002). Helper-Dependent Adenoviral Vectors Efficiently Express Transgenes in Human Dendritic Cells but Still Stimulate Antiviral Immune Responses. The Journal of Immunology. 169(8). 4651–4656. 50 indexed citations
14.
Mao, Jenny T., Jonathan Goldin, John Dermand, et al.. (2002). A Pilot Study of All- trans -Retinoic Acid for the Treatment of Human Emphysema. American Journal of Respiratory and Critical Care Medicine. 165(5). 718–723. 125 indexed citations
15.
Hertz, Cheryl J., Sylvia M. Kiertscher, Paul J. Godowski, et al.. (2001). Microbial Lipopeptides Stimulate Dendritic Cell Maturation Via Toll-Like Receptor 2. The Journal of Immunology. 166(4). 2444–2450. 297 indexed citations
16.
Thoma-Uszynski, Sybille, Sylvia M. Kiertscher, María Teresa Ochoa, et al.. (2000). Activation of Toll-Like Receptor 2 on Human Dendritic Cells Triggers Induction of IL-12, But Not IL-10. The Journal of Immunology. 165(7). 3804–3810. 204 indexed citations
17.
Roth, Michael D., et al.. (1998). Airway Inflammation in Young Marijuana and Tobacco Smokers. American Journal of Respiratory and Critical Care Medicine. 157(3). 928–937. 168 indexed citations
18.
Baldwin, Gayle Cocita, et al.. (1997). Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production. American Journal of Respiratory and Critical Care Medicine. 156(5). 1606–1613. 184 indexed citations
19.
Roth, Michael D.. (1994). Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes.. The Journal of Experimental Medicine. 179(3). 857–864. 53 indexed citations
20.
Roth, Michael D., M Pinto, Sidney H. Golub, & Hungyi Shau. (1993). Pulmonary Surfactant Inhibits Interleukin-2-induced Proliferation and the Generation of Lymphokine-activated Killer Cells. American Journal of Respiratory Cell and Molecular Biology. 9(6). 652–658. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026